Description
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX
Recorded on October 21, 2021
In this episode, Dr. Maria Alma Rodriguez from The University of Texas MD Anderson Cancer Center, joins us in discussing the long-term and late effects of cancer treatment, including strategies to support survivors with physical and psychosocial effects. Dr. Rodriguez describes barriers to follow-up care, including why some patients may be lost to this process, challenges to following a cancer survivorship plan, the importance of follow-up care coordination, and how the COVID-19 pandemic has impacted survivorship care. Join us today!
Maria Alma Rodriguez, MD, MACP, CMQ
Professor of Medicine
Department of Lymphoma/Myeloma
Medical Director
MD Anderson’s Survivorship Program
The University of Texas MD Anderson Cancer Center
Houston, TX
This podcast episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company & Janssen Biotech, Inc.
Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT
Recorded on July 2, 2024
Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton...
Published 10/25/24
Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on September 20, 2024
Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and...
Published 10/11/24